Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Dirk Bühler has worked on the following 33 EPO patent applications which have been published in the last five years:

EP11775644

METHODS FOR INDUCING THE DIFFERENTIATION OF BLOOD MONOCYTES INTO FUNCTIONAL DENDRITIC CELLS

IPC classification:
A01N 1/02, A61M 1/36
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Jens Vorberg, Bauer Vorberg Kayser mbB
Status:
EXAMINATION REQUESTED
EP11778465

METHODS FOR THE TREATMENT OF IL-1 RELATED CONDITIONS

IPC classification:
A61K 39/395, C07K 16/24
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12715356

BIOMARKERS FOR PAIN INTENSITY

IPC classification:
A61K 39/395, G01N 33/68
Applicant:
Graz University of Medicine (Medizinische Universität Graz)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12724940

MAGEA3 BINDING ANTIBODIES

IPC classification:
C07K 16/30
Applicant:
University of Zurich (Universität Zürich)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12723192

MAGEA3 BINDING ANTIBODIES

IPC classification:
C07K 16/30
Applicant:
University of Zurich (Universität Zürich)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12829385

METHODS FOR DETERMINING RESPONSIVENESS TO A DIHYDROFOLATE REDUCTASE INHIBITOR

IPC classification:
A61P 35/00, C07H 21/00, C12Q 1/68, C40B 30/06
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11838922

A2A ANTAGONISTS AS COGNITION AND MOTOR FUNCTION ENHANCERS

IPC classification:
A61K 9/00, A61K 31/198, A61K 31/44
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13158164

Method of generating a medical suggestion as a support in medical decision making

IPC classification:
G06F 19/00
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP12795978

ANTI-CD98 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61P 35/00, C07K 16/28
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Jones Day
Status:
EXAMINATION IN PROGRESS
EP12806868

METHODS FOR TREATING ACNE

IPC classification:
A61K 39/395, A61P 17/10, C07K 16/24
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13701317

HUMANIZED ANTIBODIES WITH ULTRALONG CDR3S

IPC classification:
C07K 14/54, C07K 16/00, C07K 16/10, C07K 16/46, C07K 19/00
Applicant:
The Scripps Research Institute
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12852317

BINDING MOLECULES SPECIFIC FOR HER3 AND USES THEREOF

IPC classification:
C07K 16/40
Applicant:
MedImmune, LLC
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14166974

Methods and compositions for generation of germline human antibody genes

IPC classification:
C07H 21/04, C07K 16/00, C12N 9/00, C12N 9/50, C12N 15/13, C12P 19/34, C12Q 1/68
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13718839

HIGH COMPLEXITY siRNA POOLS

IPC classification:
A61K 31/713, C12N 15/113
Applicant:
University of Regensburg (Universität Regensburg)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14188580

Methods for the treatment of gout

IPC classification:
A61K 39/00, A61K 39/395, A61K 45/06, C07K 16/24
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13798617

CD44V6-DERIVED PEPTIDES FOR TREATING METASTASIZING CANCERS

IPC classification:
A61K 38/17, A61P 35/00
Applicant:
Karlsruher Institut für Technologie
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14191630

Controlled release hydrocodone formulations

IPC classification:
A61K 9/22, A61K 9/24, A61K 31/485
Applicant:
Euro-Celtique S.A.
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP11801672

CANCER GENE THERAPY USING NUCLEIC ACIDS ENCODING US28 AND G-PROTEIN

IPC classification:
A61K 38/16, A61K 48/00, A61P 35/00
Applicant:
Graz University of Medicine (Medizinische Universität Graz)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12701463

COMBINATION THERAPY INCLUDING TUMOR ASSOCIATED ANTIGEN BINDING ANTIBODIES

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/28, C07K 16/30
Applicant:
University of Zurich (Universität Zürich)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP11719551

DISCRETE STATES FOR USE AS BIOMARKERS

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Applicant:
University of Zurich (Universität Zürich)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11718749

COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ACTIVES

IPC classification:
A61K 9/16, A61K 9/20
Applicant:
Euro-Celtique S.A.
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP11718748

MANUFACTURING OF ACTIVE-FREE GRANULES AND TABLETS COMPRISING THE SAME

IPC classification:
A61K 9/20
Applicant:
Euro-Celtique S.A.
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP16158254

METHODS FOR TREATING ACNE

IPC classification:
A61K 39/395, A61P 17/10, C07K 16/24
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP10745125

PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS

IPC classification:
C12N 15/62, C12N 15/77, C12P 13/08, C12P 13/20, C12R 1/15
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP14798848

HYDROMORPHONE AND NALOXONE FOR TREATMENT OF PAIN AND OPIOID BOWEL DYSFUNCTION SYNDROME

IPC classification:
A61K 31/485, A61K 45/06, A61P 1/00, A61P 29/00
Applicant:
Euro-Celtique S.A.
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP10857022

PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY DISORDER, CONTAINING N-ACETYL-L-CYSTEINE OR DERIVATIVE THEREOF

IPC classification:
A61K 31/18, A61K 31/195, A61K 31/198, A61K 31/216, A61K 31/355, A61K 31/51, A61K 31/525, A61K 31/55, A61K 31/5513, A61K 31/702, A61K 33/00, A61K 38/05, A61K 38/17, A61K 38/18, A61K 38/21, A61K 45/06, A61P 25/22
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP16704085

GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF

IPC classification:
A61K 45/06
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15700645

HERBICIDAL MIXTURE COMPRISING IMAZETHAPYR AND CYCLOXYDIM

IPC classification:
A01N 43/18, A01N 43/50, A01P 13/00
Applicant:
BASF Agrochemical Products B.V.
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP15769495

REDUCING DRUG LIKING IN A SUBJECT

IPC classification:
A61K 9/24, A61K 31/485, A61P 25/04, A61P 25/36, C07D 489/02, C07D 489/08
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15721694

KV1.3 POTASSIUM CHANNEL ANTAGONISTS

IPC classification:
C07K 14/47
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15733758

METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES

IPC classification:
A61K 35/15, A61P 35/00, C12N 5/0784
Applicant:
Yale University
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15839879

USES OF ANTI-HER3 ANTIBODIES FOR TREATING CANCER

IPC classification:
A61K 39/395, C07H 21/04, C07K 16/00
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15849576

METHOD TO REDUCE ONCOGENIC POTENTIAL OF INDUCED PLURIPOTENT STEM CELLS FROM AGED DONORS

IPC classification:
C07K 14/47, C12N 5/0735, C12N 5/074, C12N 15/12, C12N 15/85
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made

Please Sign in to use this feature